In the Clinician Update “Glitazones and Heart Failure: Critical Appraisal for the Clinician” by Chao-Hung Wang et al, which appeared in the March 18, 2003, issue of the journal (Circulation. 2003;107:1350–1354), reference 37 was inadvertently omitted during revision. Reference 37 appears below.
37. Shiomi T, Tsutsui H, Hayashidani S, et al. Pioglitazone, a peroxisome proliferator–activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation. 2002;106:3126–3132.